Actively Recruiting
Managing Anxiety in Pediatric Primary Care (MAPP)
Led by UConn Health · Updated on 2024-12-09
60
Participants Needed
1
Research Sites
114 weeks
Total Duration
On this page
Sponsors
U
UConn Health
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.
CONDITIONS
Official Title
Managing Anxiety in Pediatric Primary Care (MAPP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Youth aged 6 to 17 years
- Elevated anxiety symptoms with a Screen for Child Anxiety Rated Disorders score between 20 and 55 (parent or child report)
- Primary care providers must have a PA, RN, NP, APRN, or MD degree
- Primary care providers must work at least part time in a primary care setting
You will not qualify if you...
- Youth with medical or psychiatric conditions that contraindicate participation, including suicidality
- Youth currently receiving psychosocial mental health treatment for anxiety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UConn Health
West Hartford, Connecticut, United States, 06119
Actively Recruiting
Research Team
G
Golda S Ginsburg, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here